Cargando…

Tuberculosis infection versus anti-tumor necrosis factor therapy: screening challenges in psoriatic patients

OBJECTIVES: The aim of this study was to analyze the performance of the tuberculin skin test (TST) for screening and monitoring patients treated with anti-tumor necrosis factor agents, in a high-incidence area. METHODS: A 3-year retrospective study was carried out on 268 subjects. The study included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solovan, Caius, Chiticariu, Elena, Timofte, Adelina, Stoia-Djeska, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2012
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980725/ https://www.ncbi.nlm.nih.gov/pubmed/27536430 http://dx.doi.org/10.3109/21556660.2012.744315

Ejemplares similares

Psoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review
por: Solovan, Caius, et al.
Publicado: (2013)

Postoperative Pyoderma Gangrenosum in Association with Renal Cell Carcinoma and Chronic Lymphocytic Leukemia
por: Solovan, Caius, et al.
Publicado: (2013)

Psoriasis and tuberculosis binomial distribution?
por: Chiriac, Anca, et al.
Publicado: (2014)

From Benign Inflammatory Dermatosis to Cutaneous Lymphoma. DNA Copy Number Imbalances in Mycosis Fungoides versus Large Plaque Parapsoriasis
por: Gug, Georgiana, et al.
Publicado: (2021)

Mucosal melanomas in the elderly: challenging cases and review of the literature
por: Baderca, Flavia, et al.
Publicado: (2014)

Generalized Molluscum contagiosum in an HIV infected patient
por: Roşca, Ovidiu, et al.
Publicado: (2014)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area
por: Shimabuco, Andrea Yukie, et al.
Publicado: (2020)

Unusual foreign body in the sigmoid colon, chronic alcohol abuse, and Fournier gangrene: a case report
por: Schulz, Dietmar, et al.
Publicado: (2015)

Safety of Biologics for Psoriatic Patients with Latent Tuberculosis
por: Yuan, Liyan, et al.
Publicado: (2023)

Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: Real-World Data from a Care Center in Romania
por: Lupea-Chilom, Doriana-Sorina, et al.
Publicado: (2023)

Basal cell carcinomas in elderly patients treated by cryotherapy
por: Chiriac, Anca, et al.
Publicado: (2013)

CNARA: reliability assessment for genomic copy number profiles
por: Ai, Ni, et al.
Publicado: (2016)

Cutaneous factitia in elderly patients: alarm signal for psychiatric disorders
por: Chiriac, Anca, et al.
Publicado: (2014)

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
por: Thorlund, Kristian, et al.
Publicado: (2012)

A qualitative study of patients’ experiences of screening for psoriatic arthritis
por: Silverthorne, Christine A., et al.
Publicado: (2022)

Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US
por: Strand, Vibeke, et al.
Publicado: (2016)

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
por: Corrado, Addolorata, et al.
Publicado: (2017)

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
por: Rudwaleit, Martin, et al.
Publicado: (2010)

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies
por: Saad, Amr A, et al.
Publicado: (2010)

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis [Corrigendum]
Publicado: (2014)

Psoriatic Disease and Tuberculosis Nowadays
por: Balato, Nicola, et al.
Publicado: (2012)

Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment
por: Benhadou, Farida, et al.
Publicado: (2021)

Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons
por: Babudieri, Sergio, et al.
Publicado: (2012)

Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor Antagonists
por: Wu, Chun-Ying, et al.
Publicado: (2016)

Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19
por: ŞEN, Nesrin, et al.
Publicado: (2020)

A case of leukocytoclastic vasculitis associated with anti-tumor necrosis factor therapy
por: Sikorska, Dorota, et al.
Publicado: (2018)

Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Wang, Chrong-Reen, et al.
Publicado: (2021)

Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy
por: Çekiç, Cem, et al.
Publicado: (2015)

Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire
por: You, Hyang-Suk, et al.
Publicado: (2015)

A preliminary study of microRNA expression in different types of primary melanoma
por: Gencia, Ioana, et al.
Publicado: (2020)

Lymph node and pulmonary tuberculosis during upadacitinib treatment in a psoriatic arthritis patient
por: Valor-Méndez, Larissa, et al.
Publicado: (2022)

Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
por: Park, Jinkyeong, et al.
Publicado: (2023)

A Pilot Study of the Association of Tumor Necrosis Factor Alpha Polymorphisms with Psoriatic Arthritis in the Romanian Population
por: Popa, Olivia M., et al.
Publicado: (2011)

Tumor Necrosis Factor and Splenectomy
por: Yavaşoğlu, İrfan
Publicado: (2016)

Brodalumab in the treatment of psoriatic arthritis – the latest reports
por: Banaszczyk, Katarzyna
Publicado: (2021)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

The second shot to walled‐off necrosis: The sooner the better versus sooner or later
por: Sato, Tatsuya, et al.
Publicado: (2022)

Paradoxical response with increased tumor necrosis factor-α levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis
por: Watanabe, Sho, et al.
Publicado: (2017)

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists
por: Hamdi, Haïfa, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_akmrd99s7ddb67c5ug78js55na